Nevertheless, HDAC inhibitors have shown their potential to modulate tumor suppressor and/or oncogene expressions, which make it increasingly tempting to consider HDAC inhibitors as one of the anti-cancer drugs [128–133]. This evidence concerns the gene HDAC9 and neoplasm.